Press release from Companies: WntResearch har erhållit godkännanden från brittiska myndigheter för justerade doser i fas Ib-studien med Foxy-5

Press release from Companies: WntResearch has received approval from the UK authorities for adjusted doses in the Phase 1b study with Foxy-5

Press release from Companies: WntResearch has received approval from the UK authorities for adjusted doses in the Phase 1b study with Foxy-5

Press release from Companies: WntResearch has received approval from the UK authorities for adjusted doses in the Phase 1b study with Foxy-5

Press release from Companies: WntResearch has received approval from the UK authorities for adjusted doses in the Phase 1b study with Foxy-5

Press release from Companies: WntResearch offentliggör emissionsmemorandum i samband med inbjudan till teckning av units i WntResearch

Press release from Companies: WntResearch offentliggör emissionsmemorandum i samband med inbjudan till teckning av units i WntResearch

Press release from Companies: WntResearch lämnar uppdatering om den pågående fas Ib-studien med Foxy-5 - ett potentiellt nytt läkemedel mot tumörspridning

Press release from Companies: WntResearch provides update on ongoing Phase Ib study with Foxy-5 - a potential new drug to inhibit the spreading of tumors

Press release from Companies: WntResearch lämnar uppdatering om den pågående fas Ib-studien med Foxy-5 - ett potentiellt nytt läkemedel mot tumörspridning

Press release from Companies: WntResearch provides update on ongoing Phase Ib study with Foxy-5 - a potential new drug to inhibit the spreading of tumors

Press release from Companies: Beslutar om företrädesemission av units, bestående av aktier och teckningsoptioner